Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura

Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus

(2009) Marie-Luise Sixt et al.   BRAIN

Genetic Enhancement of Calcitonin Gene-Related Peptide-Induced Central Sensitization to Mechanical Stimuli in Mice

(2009) Blanca Marquez de Prado et al.   JOURNAL OF PAIN

The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs

(2009) Carlos M. Villalón et al.   PHARMACOLOGY & THERAPEUTICS

Familial Hemiplegic Migraine Type 2 does not Share Hypersensitivity to Nitric Oxide with Common Types of Migraine

(2008) JM Hansen et al.   CEPHALALGIA

Posterior Cerebral Hypoperfusion in Migraine Without Aura

(2008) M Denuelle et al.   CEPHALALGIA

Familial Hemiplegic Migraine Type 1 Shows no Hypersensitivity to Nitric Oxide

(2008) JM Hansen et al.   CEPHALALGIA

Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients

(2008) L. H. Lassen et al.   JOURNAL OF HEADACHE AND PAIN

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

(2008) Tony W Ho et al.   LANCET

Calcitonin gene-related peptide does not cause the familial hemiplegic migraine phenotype

(2008) J. M. Hansen et al.   NEUROLOGY